1
|
Bergstrand CG and Czar B: Demonstration of
a new protein fraction in serum from the human fetus. Scand J Clin
Lab Invest. 8:174–179. 1956. View Article : Google Scholar : PubMed/NCBI
|
2
|
Hamanaka W, Yoneda S, Shirakusa T,
Shirahama H, Tashiro Y, Iwasaki A, Shiraishi T and Tsuru H:
Alpha-fetoprotein (AFP)-producing adrenocortical carcinoma-long
survival with various therapeutic strategies including a lung
resection: Report of a case. Surg Today. 38:275–278. 2008.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Saito S, Hatano T, Hayakawa M, Koyama Y,
Ohsawa A and Iwamasa T: Studies on alpha-fetoprotein produced by
renal cell carcinoma. Cancer. 63:544–549. 1989. View Article : Google Scholar : PubMed/NCBI
|
4
|
Bourreille J, Metayer P, Sauger F, Matray
F and Fondimare A: [Existence of alpha feto protein during
gastric-origin secondary cancer of the liver]. Presse Med.
78:1277–1278. 1970.PubMed/NCBI
|
5
|
Chang YC, Nagasue N, Abe S, Kohno H,
Yamanoi A, Uchida M and Nakamura T: The characters of AFP-producing
early gastric cancer. Nihon Geka Gakkai Zasshi. 91:1574–1580.
1990.(In Japanese). PubMed/NCBI
|
6
|
Motoyama T, Aizawa K, Watanabe H, Fukase M
and Saito K: alpha-Fetoprotein producing gastric carcinomas: A
comparative study of three different subtypes. Acta Pathol Jpn.
43:654–661. 1993.PubMed/NCBI
|
7
|
Chang YC, Nagasue N, Abe S, Taniura H,
Kumar DD and Nakamura T: Comparison between the clinicopathologic
features of AFP-positive and AFP-negative gastric cancers. Am J
Gastroenterol. 87:321–325. 1992.PubMed/NCBI
|
8
|
Koide N, Nishio A, Igarashi J, Kajikawa S,
Adachi W and Amano J: Alpha-fetoprotein-producing gastric cancer:
Histochemical analysis of cell proliferation, apoptosis, and
angiogenesis. Am J Gastroenterol. 94:1658–1663. 1999. View Article : Google Scholar : PubMed/NCBI
|
9
|
Greene FL, Page DL and Fleming ID: AJCC
cancer staging manual. 6th. Springer; New York: 2002, View Article : Google Scholar
|
10
|
Laurén PA and Nevalainen TJ: Epidemiology
of intestinal and diffuse types of gastric carcinoma. A time-trend
study in Finland with comparison between studies from high- and
low-risk areas. Cancer. 71:2926–2933. 1993. View Article : Google Scholar : PubMed/NCBI
|
11
|
Yamagata T, Yamagata Y, Nakanishi M,
Matsunaga K, Minakata Y and Ichinose M: A case of primary lung
cancer producing alpha-fetoprotein. Can Respir J. 11:504–506. 2004.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Matsueda K, Yamamoto H, Yoshida Y and
Notohara K: Hepatoid carcinoma of the pancreas producing protein
induced by vitamin K absence or antagonist II (PIVKA-II) and
alpha-fetoprotein (AFP). J Gastroenterol. 41:1011–1019. 2006.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Kinjo T, Taniguchi H, Kushima R, Sekine S,
Oda I, Saka M, Gotoda T, Kinjo F, Fujita J and Shimoda T:
Histologic and immunohistochemical analyses of
α-fetoprotein-producing cancer of the stomach. Am J Surg Pathol.
36:56–65. 2012. View Article : Google Scholar : PubMed/NCBI
|
14
|
Cappetta A, Bergamo F, Mescoli C, Lonardi
S, Rugge M and Zagonel V: Hepatoid adenocarcinoma of the colon:
What should we target? Pathol Oncol Res. 18:93–96. 2012. View Article : Google Scholar : PubMed/NCBI
|
15
|
Kawamura N, Hatano K, Kakuta Y, Takada T,
Hara T and Yamaguchi S: [A case of hepatoid adenocarcinoma of the
urinary bladder]. Hinyokika Kiyo. 55:619–622. 2009.PubMed/NCBI
|
16
|
Isonishi S, Ogura A, Kiyokawa T, Suzuki M,
Kunito S, Hirama M, Tachibana T, Ochiai K and Tanaka T:
Alpha-fetoprotein (AFP)-producing ovarian tumor in an elderly
woman. Int J Clin Oncol. 14:70–73. 2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
McIntire KR, Waldmann TA, Moertel CG and
Go VL: Serum alpha-fetoprotein in patients with neoplasms of the
gastrointestinal tract. Cancer Res. 35:991–996. 1975.PubMed/NCBI
|
18
|
Deng J, You Q, Gao Y, Yu Q, Zhao P, Zheng
Y, Fang W, Xu N and Teng L: Prognostic value of perineural invasion
in gastric cancer: A systematic review and meta-analysis. PLoS One.
9:e889072014. View Article : Google Scholar : PubMed/NCBI
|
19
|
Dicken BJ, Graham K, Hamilton SM, Andrews
S, Lai R, Listgarten J, Jhangri GS, Saunders LD, Damaraju S and
Cass C: Lymphovascular invasion is associated with poor survival in
gastric cancer: An application of gene-expression and tissue array
techniques. Ann Surg. 243:64–73. 2006. View Article : Google Scholar : PubMed/NCBI
|
20
|
Talamonti MS, Kim SP, Yao KA, Wayne JD,
Feinglass J, Bennett CL and Rao S: Surgical outcomes of patients
with gastric carcinoma: The importance of primary tumor location
and microvessel invasion. Surgery. 134:720–727; discussion 727–729.
2003. View Article : Google Scholar : PubMed/NCBI
|
21
|
Liu X, Cheng Y, Sheng W, Lu H, Xu Y, Long
Z, Zhu H and Wang Y: Clinicopathologic features and prognostic
factors in alpha-fetoprotein-producing gastric cancers: Analysis of
104 cases. J Surg Oncol. 102:249–255. 2010. View Article : Google Scholar : PubMed/NCBI
|
22
|
Matsumoto K and Nakamura T: Hepatocyte
growth factor (HGF) as a tissue organizer for organogenesis and
regeneration. Biochem Biophys Res Commun. 239:639–644. 1997.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Halaban R, Rubin JS, Funasaka Y, Cobb M,
Boulton T, Faletto D, Rosen E, Chan A, Yoko K, White W, et al: Met
and hepatocyte growth factor/scatter factor signal transduction in
normal melanocytes and melanoma cells. Oncogene. 7:2195–2206.
1992.PubMed/NCBI
|
24
|
Tajima H, Matsumoto K and Nakamura T:
Regulation of cell growth and motility by hepatocyte growth factor
and receptor expression in various cell species. Exp Cell Res.
202:423–431. 1992. View Article : Google Scholar : PubMed/NCBI
|
25
|
Matsumoto K and Nakamura T: Hepatocyte
growth factor: Molecular structure, roles in liver regeneration,
and other biological functions. Crit Rev Oncog. 3:27–54.
1992.PubMed/NCBI
|
26
|
Amemiya H, Kono K, Mori Y, Takahashi A,
Ichihara F, Iizuka H, Sekikawa T and Matsumoto Y: High frequency of
c-Met expression in gastric cancers producing alpha- fetoprotein.
Oncology. 59:145–151. 2000. View Article : Google Scholar : PubMed/NCBI
|
27
|
Zhang JF, Shi SS, Shao YF and Zhang HZ:
Clinicopathological and prognostic features of hepatoid
adenocarcinoma of the stomach. Chin Med J (Engl). 124:1470–1476.
2011.PubMed/NCBI
|
28
|
Chun H and Kwon SJ: Clinicopathological
characteristics of alpha-fetoprotein-producing gastric cancer. J
Gastric Cancer. 11:23–30. 2011. View Article : Google Scholar : PubMed/NCBI
|
29
|
Ucar E, Semerci E, Ustun H, Yetim T,
Huzmeli C and Gullu M: Prognostic value of preoperative CEA CA
19-9, CA 72-4, and AFP levels in gastric cancer. Adv Ther.
25:1075–1084. 2008. View Article : Google Scholar : PubMed/NCBI
|
30
|
Liu X, Cheng Y, Sheng W, Lu H, Xu X, Xu Y,
Long Z, Zhu H and Wang Y: Analysis of clinicopathologic features
and prognostic factors in hepatoid adenocarcinoma of the stomach.
Am J Surg Pathol. 34:1465–1471. 2010. View Article : Google Scholar : PubMed/NCBI
|
31
|
Hirajima S, Komatsu S, Ichikawa D, Kubota
T, Okamoto K, Shiozaki A, Fujiwara H, Konishi H, Ikoma H and Otsuji
E: Liver metastasis is the only independent prognostic factor in
AFP-producing gastric cancer. World J Gastroenterol. 19:6055–6061.
2013. View Article : Google Scholar : PubMed/NCBI
|
32
|
Adachi Y, Tsuchihashi J, Shiraishi N,
Yasuda K, Etoh T and Kitano S: AFP-producing gastric carcinoma:
Multivariate analysis of prognostic factors in 270 patients.
Oncology. 65:95–101. 2003. View Article : Google Scholar : PubMed/NCBI
|
33
|
Chang YC, Nagasue N, Kohno H, Taniura H,
Uchida M, Yamanoi A, Kimoto T and Nakamura T: Clinicopathologic
features and long-term results of alpha-fetoprotein-producing
gastric cancer. Am J Gastroenterol. 85:1480–1485. 1990.PubMed/NCBI
|
34
|
Wang D, Li C, Xu Y, Xing Y, Qu L, Guo Y,
Zhang Y, Sun X and Suo J: Clinicopathological characteristics and
prognosis of alpha-fetoprotein positive gastric cancer in Chinese
patients. Int J Clin Exp Pathol. 8:6345–6355. 2015.PubMed/NCBI
|
35
|
Chen T, Xu XY and Zhou PH: Emerging
molecular classifications and therapeutic implications for gastric
cancer. Chin J Cancer. 35:492016. View Article : Google Scholar : PubMed/NCBI
|